Clinical Investigation| Volume 364, ISSUE 1, P23-28, July 2022

Helicobacter pylori versus platelet-to-spleen ratio as a risk factor for variceal bleeding in patients with liver-cirrhosis-related portal hypertension

Published:January 02, 2022DOI:


      Background Acute upper gastrointestinal (GIT) bleeding is a common medical emergency clinically manifested by hematemesis and/or melena. This study aimed to elucidate the roles of Helicobacter pylori and the platelet-spleen ratio as risk factors for variceal bleeding in patients with portal hypertension secondary to liver cirrhosis.
      Methods The study was conducted on 200 patients with liver cirrhosis of various etiologies who were divided into two groups: group 1 included 100 patients with liver cirrhosis and portal hypertension with or without a history of upper GIT bleeding, and group 2 included 100 patients with liver cirrhosis without portal hypertension. Upper GIT endoscopy was performed, and biopsy samples were taken from the gastric antral mucosa for rapid urease testing. The platelet-spleen diameter ratio was calculated for all patients.
      Results In group 1, most patients who had a history of variceal bleeding were H. pylori-negative whereas most patients without a history of variceal bleeding were H. pylori-positive, implying that H. pylori may play a significant role as a protective factor against variceal bleeding. The calculated odds ratio for the rapid urease test was low (0.851), whereas the calculated odds ratio for the platelet-spleen diameter ratio was higher (9.766) than that for the rapid urease test. Thus, the rapid urease test plays a significantly higher role than the platelet-spleen ratio as a risk factor for bleeding (p-value = 0.001).
      Conclusions H. pylori has a more significant relationship with upper GIT bleeding than the platelet-spleen diameter ratio.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Merli M.
        • Nicolini G.
        • Angeloni S.
        • et al.
        Incidence and natural history of small esophageal varices in cirrhotic patients.
        J Hepatol. 2003; 38: 266-272
        • Gatenby P.
        • Soon Y.
        Barrett's esophagus: evidence from the current metaanalyses.
        World J Gastrointest Pathophysiol. 2014; 5: 178-187
        • Schulz C.
        • Schutte K.
        • Malfertheiner P.
        • Does H.
        Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.
        J Clin Gastroenterol. 2014; 48: 491-499
        • De Franchis R.
        • Faculty B.V.I.
        Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension.
        J Hepatol. 2015; 63: 743-752
        • González-Ojeda A.
        • Cervantes-Guevara G.
        • Chávez-Sánchez M.
        • et al.
        Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis.
        World J Gastroenterol. 2014; 20: 2079-2084
        • Shibata S.
        • Umemura T.
        • Yamazaki T.
        • et al.
        Liver stiffness-spleen size- to–platelet ratio: risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
        Hepatol Res. 2016; 46: 884-889
        • Sarin S.K.
        • Lahoti D.
        • Saxena S.P.
        • Murthy N.S.
        • Prevalence M.U.K.
        classification and natural history of gastric varices: a long-termfollow-up study in 568 portal hypertension patients.
        Hepatology. 1992; 16: 1343-1349
        • Lee Y.C.
        • Chiang T.H.
        • Chou C.K.
        • et al.
        Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis.
        Gastroenterology. 2016; 150 (e5): 1113-1124
        • Simonetto D.A.
        • Liu M.
        • Kamath P.S.
        Portal hypertension and related complications: diagnosis and management.
        Mayo Clin Proc. 2019; 94: 714-726
        • Fouad T.R.
        • Abdelsameea E.
        • Abdel-Razek W.
        • et al.
        Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: post therapeutic outcome and prognostic indicators.
        J Gastroenterol Hepatol. 2019; 34 (September): 1604-1610
        • Ripoll C.
        • Groszmann R.
        • Garcia-Tsao G.
        • et al.
        Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
        Gastroenterology. 2007; 133: 481-488
        • Testa R.
        • Testa E.
        • Giannini E.
        • et al.
        Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index.
        J Intern Med. 2006; 260: 142-150
        • Mattos A.Z.
        • Mattos A.A.
        • Vianna F.F.
        • Musskopf M.I.
        • Pereira-Lima J.C.
        • Maciel A.C.
        Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices.
        Arq Gastroenterol. 2010; 47: 275-278
        • Jamil Z.
        • Malik M.
        • Durrani A.A.
        Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis.
        Turk J Gastroenterol. 2017; 28: 347-352
        • Ying L.
        • Lin X.
        • Xie Z.L.
        • Hu Y.P.
        • Shi K.Q.
        Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis.
        Dig Dis Sci. 2012; 57: 1672-1681
        • Abd-Elsalam S.
        • Habba E.
        • Elkhalawany W.
        • et al.
        Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis.
        Med Baltim. 2016; 95: e3853
        • Veijola L.I.
        • Oksanen A.M.
        • Sipponen P.I.
        • Rautelin H.I.
        Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
        World J Gastroenterol. 2010; 16: 83-88
        • Abbasi A.
        • Butt N.
        • Bhutto A.R.
        • Munir S.M.
        Correlation of thrombocytopenia with grading of esophageal varices in chronic liver disease patients.
        J Coll Physicians Surg Pak. 2010; 20: 369-372